Durable Complete Remission of Leptomeningeal Melanoma by Intrathecal Methotrexate Maintained with Systemic Ipilimumab
Carmen Dietrich(Heidelberg University), Jessica C. Hassel(German Cancer Research Center), Andreas Steinbrecher, Rudolf Herbst(Helios Klinikum Erfurt), Martin Salzmann(Heidelberg University)
Cited by 3
Related Papers
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k
Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
|New England Journal of Medicine|2016|1.3k
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
|New England Journal of Medicine|2021|869